Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Codexis, Inc.
CDXS · SEC Filings
website
146
Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization...
Price
1.11
Market Cap
121.55 M
Float
108.12 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about CDXS
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Codexis, Inc.
CDXS · SEC Filings
108.12 M
Float
1.11
Price
121.55 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 7, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 6, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025
News
TYPE
HEADLINE
FILED AT
8-K
Codexis Reports Second Quarter 2026 Financial Results and Business Updates
Aug 11, 2026
8-K
Codexis, Inc. Completes $25 Million Common Stock Offering
Jul 27, 2026
8-K
Codexis, Inc. Announces Preliminary Financial Results for Q2 2026
Jul 23, 2026
8-K
Codexis, Inc. Announces Results of 2026 Annual Meeting of Stockholders
Jun 22, 2026
8-K
Codexis Reports First Quarter 2026 Financial Results and Reiterates Full-Year Guidance
May 7, 2026
8-K
Codexis, Inc. Announces Board Resignation and Director Class Rebalancing
Apr 14, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
REGISTERED OFFERING
Jul 24, 2026
424B5
PENDING FIXED PRICE OFFERING | Bank: Piper Sandler & Co.; Cantor Fitzgerald & Co.
Jul 23, 2026
424B5
ATM | Offering amount: $75,000,000
May 14, 2024
424B5
ATM | Offering amount: $50,000,000
May 7, 2021
424B5
4,285,715 Shares-
Dec 3, 2020
424B5
Common Stock-
Dec 2, 2020
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 13, 2025
S-8
Registration
Aug 9, 2024
S-3
SHELF | ATM | Offering amount: $200,000,000.00 EFFECTIVE
May 2, 2024
S-8
Registration
Aug 3, 2023
S-8
Registration
Aug 3, 2023
POS EX
Registration
May 4, 2023
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 28, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 28, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 24, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 24, 2025
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 25, 2024
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 25, 2024
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G/A
Opaleye Management Inc. (Filed by)
Nov 6, 2026
SCHEDULE 13G/A
Aberdeen Group plc (Filed by)
Oct 30, 2026
4
Erbez Georgia (Reporting)
Oct 14, 2026
4
MOORE ALISON (Reporting)
Oct 14, 2026
144
Form 144 - Report of proposed sale of securities
Oct 13, 2026
144
Form 144 - Report of proposed sale of securities
Oct 13, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
May 15, 2024
CORRESP
Form CORRESP - Correspondence
May 10, 2024
LETTER
Form UPLOAD - SEC-generated letter
May 10, 2024
EFFECT
Form EFFECT - Notice of Effectiveness
May 5, 2023
CT ORDER
Form CT ORDER - Confidential treatment order
Nov 22, 2021
CT ORDER
Form CT ORDER - Confidential treatment order
Nov 17, 2021
